ID
38019
Beschrijving
Study ID: 105036 Clinical Study ID: 105036 Study Title: A single-blind, randomized, placebo-controlled study to investigate the safety, tolerability, and potential effects on betamethasone pharmacokinetics of a co-administered infusion of GSK221149A in healthy female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: betamethasone Trade Name: Retosiban Study Indication: Women's Health & Pregnancy - Other, pre-term labour
Trefwoorden
Versies (1)
- 09-09-19 09-09-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
9 september 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Betamethasone pharmacokinetics of a co-administered infusion of GSK221149A; 105036
Concomitant Medication(s)
- StudyEvent: ODM
Similar models
Concomitant Medication(s)
- StudyEvent: ODM
C2348184 (UMLS CUI [1,2])
C2360065 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C1519795 (UMLS CUI [1,2])
C0439603 (UMLS CUI [1,2])
C0013153 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,3])
C2347852 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,3])